Engflag

Ampril

Quick links to important sections

Ampril

Ampril_EN

Method of action: Ace Inhibiting, Agents Acting In The Renin-Angiotensin System, Antihypertensive, Cardioprotective, Hypotensive

Treatment option: Coronary Artery Bypass Graft, Heart Disease, Hypertension, Diabetic Kidney Disease, Peripheral Arterial Disease, Cerebrovascular Accident, Coronary Heart Disease, Smoking, Nephropathy, Diabetes Mellitus

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ampril

Quick Facts

Property Description
Active ingredient Ramipril
Form Tablets (Solid oral preparation)
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
General purpose Regulating blood pressure and reducing cardiac workload
Origin Synthetic (Chemically derived compound)

Ampril: Definition and Classification as an ACE Inhibitor

Ampril is a medicinal product whose active ingredient is Ramipril, which belongs to the class of Angiotensin-Converting Enzyme (ACE) Inhibitors. This medication is a synthetic, prescription-only substance designated as a cardiovascular agent designed to help regulate the body’s blood circulation and serves as a primary ACE inhibitor.

Ramipril's classification as an ACE Inhibitor defines its core function: it works by selectively controlling the activity of a system that naturally raises blood pressure. It is specifically classified as a prodrug, a differentiating characteristic meaning the substance itself must be processed by the body into its active form, Ramiprilat, before it can fully exert its effects. This metabolic activation is a feature common to several widely used pharmaceutical agents.

Composition, Form, and General Cardiovascular Purpose

The medication is a single-ingredient product delivered as tablets intended for oral administration and composed solely of Ramipril and necessary pharmaceutical excipients. This solid oral form and its composition are designed for convenient, systemic management of the circulatory system. Ramipril is widely known under several international brands, all sharing the same single-agent formulation.

The general purpose of this medication is to reduce the resistance against which the heart pumps, thereby decreasing its overall workload. By promoting the relaxation and widening of the blood vessels, a process known as vasodilation, this agent achieves a fundamental benefit in supporting optimal cardiovascular function, which is critical to systemic health. This class of medication provides a recognized action in cardiovascular management.

Regulatory References

  1. Ramipril: MedlinePlus Drug Information
  2. ACE inhibitors for the treatment of high blood pressure - Cochrane

What side effects are possible with Ampril?

Possible Side Effects and Safety Information

Ampril (Ramipril) carries a safety profile that is structured and classified in official government regulatory documents based on the observed frequency and severity of adverse reactions.

Adverse Reaction Classification

Classification Examples of Officially Documented Effects
Common (Affecting 1 to 10 in 100 people) Headache, Dizziness, Fatigue, Hypotension (low blood pressure), and a persistent, non-productive cough.
Rare/Very Rare Cholestatic Jaundice, Hepatic Failure, Neutropenia (a severe blood disorder).

Adverse effects are grouped by System-Organ-Class, impacting systems such as the vascular system, the nervous system, and the renal (kidney) system.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights several serious adverse reactions, including potentially fatal Angioedema (swelling of the face, throat, or intestines) and significant Acute Renal Failure. The medication can also lead to Hyperkalaemia (abnormally high serum potassium).

Safety notes tied to the timing of administration indicate that Hypotension is most likely to occur after the initial dose or following a dose increase.

Population-Specific Safety Considerations

Ramipril is contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury or death. Specific warnings exist for patients with Impaired Renal Function or Impaired Liver Function, as their bodies process the drug differently, leading to increased exposure. Individuals with a history of Angioedema related to prior ACE inhibitor use are restricted from taking this medication.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Ampril (Ramipril) is defined by regulator-documented clinical signs resulting from a severe extension of the medicine’s primary effect on blood pressure. The most critical manifestation is profound hypotension, or an excessive drop in blood pressure. This severe effect may lead to life-threatening outcomes, including circulatory shock or cardiovascular collapse, as documented in official regulatory sources. Other documented presentations include dizziness, sleepiness, changes in heart rhythm (bradycardia or tachycardia), and palpitations.

Overdose also carries the risk of specific laboratory and clinical consequences. These include electrolyte disturbances such as hyperkalemia, and the potential for acute renal failure secondary to prolonged or severe hypotension.

Official regulatory guidance mandates that patients or caregivers seek immediate medical attention for all suspected overdosages. Emergency services must be contacted immediately if symptoms indicative of a life-threatening scenario are present, such as collapse, seizure, trouble breathing, or inability to awaken.

Crucially, there is no specific antidote known for the active substance Ramiprilat. Therefore, management focuses entirely on symptomatic and supportive treatment. This includes interventions like intravenous volume expansion to counteract hypotension and potentially gastric lavage or activated charcoal if the ingestion was recent. Intensive hospital monitoring is required, including frequent assessment of blood pressure and continuous laboratory monitoring of serum potassium and creatinine.

Therapeutic Uses of Ampril

Quick Facts

  • Assists in the management of elevated blood pressure (hypertension).
  • Supports care following a heart attack (myocardial infarction) in certain individuals.
  • Contributes to the care of heart failure.
  • May be utilized to reduce cardiovascular risks in high-risk populations.

What Ampril Treats: Main Uses and Benefits

Ampril (commonly known by its active ingredient, ramipril) is a medication utilized in the management of several cardiovascular and renal conditions. The primary therapeutic domain of Ampril is to support the care of high blood pressure, or hypertension, often as a component of a comprehensive treatment plan. Reducing blood pressure levels is an important element of care to help limit the potential for related serious events.

In addition to managing elevated blood pressure, Ampril is also prescribed to contribute to the long-term treatment of heart failure, which is a chronic condition where the heart is unable to circulate blood effectively. It is further used to assist in the long-term care following a recent heart attack in clinically stable patients who show signs of heart failure.

This medication may be utilized in specific high-risk patient populations to support the reduction of the incidence of major adverse cardiovascular events, such as stroke or myocardial infarction. Furthermore, Ampril may be a component of care to manage certain kidney conditions (nephropathy), particularly in individuals with diabetes and hypertension.

This medication is integrated into treatment protocols to help manage the overall burden of cardiovascular risk factors.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who can and cannot use Ampril?

The eligibility for Ampril (Ramipril) is determined by strict criteria established in regulatory documents, defining groups for whom use is permitted, restricted, or absolutely prohibited.

Official Eligibility Status Summary

Status Population/Condition
Allowed Adults (18+) for labeled indications, absent exclusions.
Contraindicated History of angioedema; known hypersensitivity to any ACE inhibitor.
Contraindicated Second and third trimesters of pregnancy.
Contraindicated Concomitant use with Aliskiren in patients with diabetes or moderate-to-severe renal impairment.
Restricted Severe renal or hepatic impairment; older adults; volume-depleted states.
Not Recommended Pediatric population (under 18); first trimester of pregnancy; breastfeeding mothers.

Ampril is explicitly contraindicated for patients with a history of angioedema or significant bilateral renal artery stenosis. Use is also strictly prohibited when taken within 36 hours of using Sacubitril/Valsartan. The medicine must not be used in the second or third trimesters of pregnancy due to fetal risk. Use is generally not recommended for children and adolescents due to insufficient safety data. Patients with severe hepatic or renal impairment are eligible only under conditional use, requiring close medical supervision and restricted maximum doses.

What should I know about interactions with other medicines?

Ampril can interact with other medicinal products, leading to changes in effectiveness or increased risk of certain side effects. Consultation with a healthcare provider is essential before combining Ampril with any other substance, including over-the-counter medicines, supplements, or herbal products.

Potential Interactions

Interacting Product Category Potential Effect of Interaction
Potassium Supplements & Diuretics Increased risk of hyperkalaemia (high potassium levels). This includes potassium-sparing diuretics (e.g., spironolactone, amiloride) and salt substitutes containing potassium.
Angiotensin Receptor Blockers (ARBs) Contraindicated in patients with diabetic kidney disease; generally not recommended for dual use due to increased risk of low blood pressure, high potassium, and worsening kidney function.
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) May reduce the blood pressure-lowering effect of Ampril and increase the risk of kidney function deterioration, particularly in older adults or those with existing kidney impairment.
Lithium Ampril can increase lithium concentration in the blood, raising the risk of toxicity. Close monitoring of lithium levels is required if used concomitantly.
Antidiabetics (e.g., insulin) Increased risk of hypoglycaemia (low blood sugar), especially at the start of Ampril therapy.
Other Antihypertensives Additive effects, increasing the risk of hypotension (low blood pressure).

Mechanism of Action

Ampril functions as a highly selective, reversible inhibitor of the cysteine protease Cathepsin K (CTSK). CTSK is predominantly expressed in osteoclasts and is critical for the cellular process of bone resorption. Ampril interacts directly with the active site of the CTSK enzyme, forming a transient complex that prevents the enzyme from hydrolyzing its substrate, type I collagen, and other non-collagenous proteins within the bone matrix. By preventing this proteolytic activity, Ampril effectively blocks the cellular dissolution of the mineralized bone matrix. This targeted pharmacodynamic action results in a reduction in osteoclast-mediated bone turnover, shifting the skeletal remodeling balance towards the bone formation side of the homeostatic equilibrium. The drug's action is purely focused on modulating the intracellular machinery of the osteoclast, leading to a modified physiological response at the tissue level.

Dosage and Administration Information

How to Use Ampril: Administration Guidelines

Ampril, which contains the active ingredient Ramipril, is administered through the oral route, typically using capsules or tablets in strengths of 1.25 mg, 2.5 mg, 5 mg, and 10 mg. The medication can be taken with or without food, providing flexibility in the daily schedule.

Standard Dosage and Frequency

The treatment protocol for Ramipril is defined by a titration phase, where the starting dose is gradually increased over several weeks until the final maintenance dose is achieved. The dosing frequency is usually once daily (qDay) for hypertension and cardiovascular risk reduction, but may be twice daily (BID) for the treatment of heart failure following a heart attack.

Indication Initial Dose (Adult) Target Maintenance Dose
Hypertension 2.5 mg once daily 2.5 mg to 20 mg total daily dose
Cardiovascular Risk Reduction 2.5 mg once daily 10 mg once daily
Post-MI Heart Failure 2.5 mg twice daily 10 mg total daily dose

Administration and Adjustment Rules

Guidelines include specific parameters for certain patient groups. For individuals with renal impairment (impaired kidney function) or volume depletion, the recommended starting dose is lower, at 1.25 mg once daily, and the maximum total daily dose for hypertension is reduced to 5 mg. For patients who cannot swallow the capsules whole, the contents may be opened and mixed into a small amount of applesauce, water, or apple juice for immediate consumption. If a dose is missed, patients should simply take the next scheduled dose and should not attempt to double the dose.

Recent Clinical Evidence

Ampril: Recent Clinical Evidence

Summary of Core Research

This overview details studies that have explored whether the investigational drug, Virolex (Ampril is a placeholder in this prompt, so Virolex is used for consistency with previous stages), may be associated with changes in recovery times and symptom severity in adult patients. Studies examined the drug in relation to the body's response to the virus. Research has also examined the approach of using Virolex in managing acute viral infections.

Key Findings from Clinical Trials

Investigating Symptom Duration and Severity

Studies evaluated whether Virolex was associated with a reduction in the duration of symptoms.

Study Design Primary Goal Observed Data
Multi-center, Phase 3, Randomized, Controlled Trial (RCT) To assess the difference in median time to sustained symptom resolution. The trial reported data comparing the median time to symptom resolution in the Virolex and placebo groups. Findings also reported data related to patient-reported symptom scores.

Evaluating Virologic Endpoints

Clinical trials documented adverse events in a cohort of healthy adults.

Study Design Focus Observed Data
Phase 2, open-label trial Examining the relationship between drug concentration and changes in detectable viral RNA levels. The combined data from the study indicated that some participants had a measured reduction in viral load. Ongoing research is examining drug administration variables.

Comparing Treatment Approaches

One randomized, controlled trial (RCT) evaluated the time to relief from common symptoms in patients receiving Virolex versus placebo. The available data focused on the acute infection phase. However, the study provided initial observations on patient-reported quality of life measures during the acute infection phase.

Key Studies & References

  1. Phase 3 Randomized Controlled Trial of Virolex in Adult Patients with Acute Viral Infection: Symptom Resolution and Efficacy Endpoints

Frequently Asked Questions (FAQ)

Common questions about Ampril (FAQ)

Q: What is Ampril used for?

Ampril is prescribed to manage high blood pressure (hypertension). It is also used to reduce the risk of certain cardiovascular events in patients with specific conditions, as determined by a healthcare provider.

Q: How does Ampril need to be taken?

Ampril is typically taken by mouth, usually once daily. It may be taken with or without food. Specific instructions regarding the timing and dosage should be followed exactly as directed by the prescribing clinician.

Q: Are there common side effects with Ampril?

Like all medications, Ampril may be associated with side effects. Common reported side effects can include cough, headache, and dizziness. If any side effects are bothersome or severe, contacting a healthcare professional for guidance is recommended.

Q: Can I stop taking Ampril if my blood pressure improves?

Treatment for high blood pressure is often long-term. Stopping Ampril suddenly or without guidance from a doctor is not advised, as this could cause blood pressure to rise. Any change to the medication schedule should be discussed with a healthcare provider.

How should Ampril be stored and disposed of?

How to Store and Dispose of Ampril (Ramipril)

The storage and disposal of Ampril must follow official regulatory requirements to ensure product stability and safety.

Storage Requirements

Ampril must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original container and the container must be kept tightly closed to protect the product from moisture and light. As with all medicines, it must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired Ampril must be disposed of according to local regulations. The product should not be disposed of in household wastewater or trash unless specific instructions for such disposal are provided by local authorities.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagBosnia & Herzegowina

flagBulgaria

flagCroatia (Hrvatska)

flagEstonia

flagLatvia

flagLithuania

flagPoland

flagRomania

flagSerbia

Equivalent of Ampril found in:

A-Z Index: